Advanced search×

Endocrine fibroblast growth factors as regulators of metabolic homeostasis

Biofactors 35(1):52-60 (2009) PMID 19319846

Endocrine fibroblast growth factors (FGFs) function as hormones that maintain specific metabolic states by controlling homeostasis of bile acid, glucose, fatty acid, phosphate, and vitamin D. Endocrine FGFs exert their biological activity through a common design of coreceptor system consisting of the Klotho gene family of transmembrane proteins and cognate FGF receptors. Moreover, expression of endocrine FGFs is regulated by nuclear receptors whose lipophilic ligands are generated under the control of these hormones in the target organs. Thus, novel endocrine axes have emerged that regulate diverse metabolic processes through feedback loops composed of the FGF, Klotho, FGF receptor, and nuclear receptor gene families. This review summarizes the role of Klotho family proteins in the regulation of metabolic activity and expression of the endocrine FGFs.

DOI: 10.1002/biof.12
Version: za2963e q8za2 q8zbe q8zcd q8zd7 q8ze5 q8zf0 q8zg0

Similar articles you may find interesting…

  1. Study on endocronological effects of radon speleotherapy on respiratory diseases.

    Int J Radiat Biol 85(3):281-90 (2009) PMID 19296342

    After statistical analysis of the data a significant decrease of cortisol levels of patients was found, which was not directly correlated with radon concentration. In the case of thyroid hormones, there were no significantly detectable changes of the hormone levels except for low radon concentration...
  2. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF...

    J Biol Chem 282(37):26687-95 (2007) PMID 17623664 PMCID 2496965

    We demonstrated that Klotho and betaKlotho, homologous single-pass transmembrane proteins that bind to FGFRs, are required for metabolic activity of FGF23 and FGF21, respectively. Here we show that, like FGF21, FGF19 also requires betaKlotho. Both FGF19 and FGF21 can signal through FGFR1-3 bound by...
  3. How fibroblast growth factor 23 works.

    J Am Soc Nephrol 18(6):1637-47 (2007) PMID 17494882

    There is a discontinuum of hereditary and acquired disorders of phosphate homeostasis that are caused by either high or low circulating levels of the novel phosphaturic hormone fibroblastic growth factor 23 (FGF23). Disorders that are caused by high circulating levels of FGF23 are characterized by h...